Latest News

Brise Pharmaceuticals Secures $20M for Innovative Pain Treatments

Arsenal April 23, 2024

Digital artwork illustrating a modern, diverse pharmaceutical sales and marketing team strategizing over virtual and augmented reality tools, with global market data floating in the air around them.

Present Condition of the Pharmaceutical Sales and Marketing Workforce.

Frank Dolan April 22, 2024

FDA Watch: Key Decisions for ImmunityBio, Aquestive, XOMA in April

Arsenal April 22, 2024

Akero vs. Madrigal: The Battle for MASH Treatment Supremacy

Arsenal April 22, 2024

Scientists in a high-tech laboratory wearing protective equipment and working together to develop a bird flu vaccine, with a detailed illustration of the H5N1 virus structure in the background and a Texas flag subtly incorporated.

Texas Biomed Working on Potential Vaccine for Bird Flu.

Frank Dolan April 19, 2024

Ensysce’s Noble Conference Presentation Now Available on IR Website

Arsenal April 19, 2024

La Jolla Institute, RevolKa Collaborate on Next-Gen Vaccine Antigens

Arsenal April 19, 2024

An artist's interpretation of a futuristic medical laboratory highlighting the successful Phase III SELECT-GCA trial for Rinvoq, with scientists examining glowing test tubes and digital screens displaying giant cell arteritis data.

Promising Outcomes from Phase III SELECT-GCA Study of Rinvoq in Treating Giant Cell Arteritis Patients.

Frank Dolan April 18, 2024

Addex Therapeutics: 2023 Financial Results and Corporate Update

Arsenal April 18, 2024

TaiGen’s TG-1000 Influenza Antiviral Completes Successful Phase III Study

Arsenal April 18, 2024

Genentech’s Subcutaneous Ocrevus Shows Promising Results in MS Patients

Arsenal April 17, 2024

An intricate digital illustration visualizing a maze made of swirling financial documents, tax forms, and calculators, with a navigational compass overlaid, highlighting the complexities of the IRA landscape.

Understanding the Changing Complexities of the IRA: A Guide.

Frank Dolan April 16, 2024

Spago Nanomedical Appoints Birgitta Rembratt Svensson as Head of CMC & Supply

Arsenal April 16, 2024

Innovent Appoints Renowned Oncology Leader Dr. Nageatte Ibrahim as CMO

Arsenal April 16, 2024

Nxera Pharma Inks Exclusive PIVLAZ™ Distribution Deal with Handok in South Korea

Arsenal April 15, 2024

4 Novel Weight Loss Drugs Poised to Disrupt the Obesity Treatment Market

Arsenal April 15, 2024

Digital art of a handshake between two corporate figures, with symbols of Novartis and Arvinas logos in the background, overlaying a futuristic laboratory working on prostate cancer treatment.

Novartis and Arvinas Enter Strategic Partnership to Advance Prostate Cancer Treatment Development.

Frank Dolan April 12, 2024

Nurix Therapeutics: $175M Public Offering Priced at $15/Share

Arsenal April 12, 2024

Rakuten Medical: COX-2 Inhibition Reduces Photoimmunotherapy-Induced Edema in Mice (AACR 2024)

Arsenal April 12, 2024

An illustration of a medical professional demonstrating diverse methods of administering SK Life Science's Xcorpi to adults suffering from partial-onset seizures, in a bright, modern clinic setting.

FDA Green-lights Novel Delivery Approaches for SK Life Science’s Xcorpi in Treating Adults with Partial-Onset Seizures.

Frank Dolan April 11, 2024

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Jiangsu Hengrui Targets $1.2 Billion IPO: A Leap Forward for Biotech Innovation

Novo Nordisk and Septerna Join Forces: A Game-Changer in Oral Obesity Drug Development

SK and Carlyle Boost Bid for bluebird bio: Major Moves in Biotech Financing and Investments

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA